Identification of Two Long Noncoding RNAs, Kcnq1ot1 and Rmst, as Biomarkers in Chronic Liver Diseases in Mice
- PMID: 39201613
- PMCID: PMC11354866
- DOI: 10.3390/ijms25168927
Identification of Two Long Noncoding RNAs, Kcnq1ot1 and Rmst, as Biomarkers in Chronic Liver Diseases in Mice
Abstract
This study investigates novel short-lived long noncoding RNAs (lncRNAs) in mice with altered expression in metabolic dysfunction-associated steatotic liver (MASH) and liver fibrosis. LncRNAs share similarities with mRNAs in their transcription by RNA polymerase II, possession of a 5' cap structure, and presence of a polyA tail. We identified two lncRNAs, Kcnq1ot1 and Rmst, significantly decreased in both conditions. These lncRNAs showed dramatic expression changes in MASH livers induced by Western diets and CCl4, and in fibrotic livers induced by CCl4 alone. The decrease was more pronounced in liver fibrosis, suggesting their potential as biomarkers for disease progression. Our findings are consistent across different fibrosis models, indicating a crucial role for these lncRNAs in MASH and liver fibrosis in mice. With MASH becoming a global health issue and its progression to fibrosis associated with hepatocarcinogenesis and poor prognosis, understanding the underlying mechanisms is critical. This research contributes to elucidating lncRNA functions in murine liver diseases and provides a foundation for developing novel therapeutic strategies targeting lncRNAs in MASH and liver fibrosis, offering new avenues for potential therapeutic interventions.
Keywords: Kcnq1ot1; Rmst; hepatocellular carcinoma; lncRNAs; mouse liver.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Genome‑wide identification of long noncoding RNAs in CCl4‑induced liver fibrosis via RNA sequencing.Mol Med Rep. 2018 Jul;18(1):299-307. doi: 10.3892/mmr.2018.8986. Epub 2018 May 7. Mol Med Rep. 2018. PMID: 29749545 Free PMC article.
-
Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases.Biomolecules. 2024 Feb 26;14(3):277. doi: 10.3390/biom14030277. Biomolecules. 2024. PMID: 38540698 Free PMC article. Review.
-
Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials.J Transl Med. 2024 Oct 14;22(1):936. doi: 10.1186/s12967-024-05686-7. J Transl Med. 2024. PMID: 39402603 Free PMC article. Clinical Trial.
-
Integrated profiling of long non-coding RNAs and mRNAs identifies novel regulators associated with liver fibrosis.Pathol Res Pract. 2018 Nov;214(11):1794-1803. doi: 10.1016/j.prp.2018.08.021. Epub 2018 Aug 28. Pathol Res Pract. 2018. PMID: 30193772
-
KCNQ1OT1: An Oncogenic Long Noncoding RNA.Biomolecules. 2021 Oct 29;11(11):1602. doi: 10.3390/biom11111602. Biomolecules. 2021. PMID: 34827600 Free PMC article. Review.
Cited by
-
Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives.Genes (Basel). 2025 Mar 29;16(4):399. doi: 10.3390/genes16040399. Genes (Basel). 2025. PMID: 40282358 Free PMC article. Review.
-
Recent Advances and Prospects in RNA Drug Development.Int J Mol Sci. 2024 Nov 15;25(22):12284. doi: 10.3390/ijms252212284. Int J Mol Sci. 2024. PMID: 39596348 Free PMC article. Review.
-
Biomolecules Interacting with Long Noncoding RNAs.Biology (Basel). 2025 Apr 19;14(4):442. doi: 10.3390/biology14040442. Biology (Basel). 2025. PMID: 40282307 Free PMC article. Review.
References
-
- Muto H., Honda T., Tanaka T., Yokoyama S., Yamamoto K., Ito T., Imai N., Ishizu Y., Maeda K., Ishikawa T., et al. Proteomic analysis reveals changes in tight junctions in the small intestinal epithelium of mice fed a high-fat diet. Nutrients. 2023;15:1473. doi: 10.3390/nu15061473. - DOI - PMC - PubMed
-
- Ito T., Ishigami M., Zou B., Tanaka T., Takahashi H., Kurosaki M., Maeda M., Thin K.N., Tanaka K., Takahashi Y., et al. The epidemiology of NAFLD and lean NAFLD in Japan: A meta-analysis with individual and forecasting analysis, 1995–2040. Hepatol. Int. 2021;15:366–379. doi: 10.1007/s12072-021-10143-4. - DOI - PubMed
-
- Tateishi R., Uchino K., Fujiwara N., Takehara T., Okanoue T., Seike M., Yoshiji H., Yatsuhashi H., Shimizu M., Torimura T., et al. A Nationwide Survey on Non-B, Non-C Hepatocellular Carcinoma in Japan: 2011–2015 Update. J. Gastroenterol. 2019;54:367–376. doi: 10.1007/s00535-018-1532-5. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous